Annual Cash & Cash Equivalents
$2.64 M
-$903.00 K-25.49%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual cash & cash equivalents is $2.64 million, with the most recent change of -$903.00 thousand (-25.49%) on December 1, 2023.
- During the last 3 years, NRSN annual cash & cash equivalents has risen by +$1.94 million (+277.68%).
- NRSN annual cash & cash equivalents is now -76.14% below its all-time high of $11.06 million, reached on December 31, 2021.
Performance
NRSN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$344.00 K
-$864.00 K-71.52%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly cash and cash equivalents is $344.00 thousand, with the most recent change of -$864.00 thousand (-71.52%) on September 1, 2024.
- Over the past year, NRSN quarterly cash and cash equivalents has dropped by -$391.00 thousand (-53.20%).
- NRSN quarterly cash and cash equivalents is now -96.89% below its all-time high of $11.06 million, reached on December 1, 2021.
Performance
NRSN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NRSN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.5% | -53.2% |
| 3 y3 years | +277.7% | -92.1% |
| 5 y5 years | +195.0% | - |
NRSN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.1% | at low | -96.9% | at low |
| 5 y | 5-year | -76.1% | +277.7% | -96.9% | at low |
| alltime | all time | -76.1% | +277.7% | -96.9% | at low |
NeuroSense Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $344.00 K(-71.5%) |
| Jun 2024 | - | $1.21 M(+64.4%) |
| Mar 2024 | - | $735.00 K(-72.2%) |
| Dec 2023 | $2.64 M(-25.5%) | $2.64 M(-44.5%) |
| Sep 2023 | - | $4.76 M(-32.9%) |
| Jun 2023 | - | $7.09 M(+421.6%) |
| Mar 2023 | - | $1.36 M(-61.6%) |
| Dec 2022 | $3.54 M | $3.54 M(-19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $4.41 M(+1.4%) |
| Jun 2022 | - | $4.35 M(-50.2%) |
| Mar 2022 | - | $8.73 M(-21.0%) |
| Dec 2021 | $11.06 M(+1482.7%) | - |
| Dec 2021 | - | $11.06 M(+1013.0%) |
| Jun 2021 | - | $994.00 K(+42.2%) |
| Dec 2020 | $699.00 K(-21.9%) | $699.00 K |
| Dec 2019 | $895.00 K | - |
FAQ
- What is NeuroSense Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual cash & cash equivalents year-on-year change?
- What is NeuroSense Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly cash and cash equivalents year-on-year change?
What is NeuroSense Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of NRSN is $2.64 M
What is the all time high annual cash & cash equivalents for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual cash & cash equivalents is $11.06 M
What is NeuroSense Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, NRSN annual cash & cash equivalents has changed by -$903.00 K (-25.49%)
What is NeuroSense Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NRSN is $344.00 K
What is the all time high quarterly cash and cash equivalents for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly cash and cash equivalents is $11.06 M
What is NeuroSense Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, NRSN quarterly cash and cash equivalents has changed by -$391.00 K (-53.20%)